Created in 2020 when Mylan merged with Pfizer's off-patent drug business, Upjohn.
This company received an S&P Global ESG Score of 27/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 7 Feb 2021). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2021)
This company has corporate social responsibility claims on its website.
Source: company website (2021)
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
Source: company website (2020)
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
Source: Open Secrets (2021)
|Revenue||US$20 billion in 2020|
- Alphapharm Pty Ltd
- Meda AB
Products / BrandsViatris Australia
Dermeze Skin Care
Dermeze Body Wash
Dymadon Pain Relief Tablets
Gastro-Stop Digestive Care
Irish Moss Cold & Flu
Tums Digestive Care
Waxsol Eye & Ear Care
Zantac Digestive Care